Kathleen Brady to Anti-Anxiety Agents
This is a "connection" page, showing publications Kathleen Brady has written about Anti-Anxiety Agents.
Connection Strength
0.826
-
A placebo-controlled trial of buspirone for the treatment of marijuana dependence. Drug Alcohol Depend. 2009 Nov 01; 105(1-2):132-8.
Score: 0.302
-
Gabapentin in comorbid anxiety and substance use. Am J Addict. 2007 Mar-Apr; 16(2):142-3.
Score: 0.255
-
Profiles of hospitalized benzodiazepine abusers. J Psychoactive Drugs. 1991 Jan-Mar; 23(1):71-2.
Score: 0.083
-
Buspirone for treatment of marijuana dependence: a pilot study. Am J Addict. 2006 Sep-Oct; 15(5):404.
Score: 0.062
-
A randomized, placebo-controlled trial of buspirone for the treatment of anxiety in opioid-dependent individuals. Am J Addict. 2004 Jan-Feb; 13(1):53-63.
Score: 0.051
-
Substance abuse and bipolar comorbidity. Psychiatr Clin North Am. 1999 Sep; 22(3):609-27, ix.
Score: 0.038
-
Types of benzodiazepines abused by chemically dependent inpatients. J Psychoactive Drugs. 1993 Oct-Dec; 25(4):315-9.
Score: 0.025
-
Divalproex in the treatment of alcohol withdrawal. Am J Drug Alcohol Abuse. 2000 Feb; 26(1):155-60.
Score: 0.010